Cargando…

Editorial: Recent Advances in Cardiotoxicity Testing

Detalles Bibliográficos
Autores principales:	Mohamed, Tamer M. A., Moslehi, Javid, Satin, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606750/ https://www.ncbi.nlm.nih.gov/pubmed/34819868 http://dx.doi.org/10.3389/fphar.2021.798189

Ejemplares similares

Editorial: Recent advances in radiation medical countermeasures
por: Tichy, Ales, et al.
Publicado: (2022)

Editorial: Recent Advances in Voltage-Gated Sodium Channels, their Pharmacology and Related Diseases
por: Chahine, Mohamed, et al.
Publicado: (2016)

Recent Progress in Environmental Toxins-Induced Cardiotoxicity and Protective Potential of Natural Products
por: Yang, Yuanying, et al.
Publicado: (2021)

Editorial: Recent advances in novel therapeutic molecules and targets for inflammatory diseases
por: Li, Feng, et al.
Publicado: (2023)

Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time?
por: Aras, Mandar A., et al.
Publicado: (2020)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Associated Cardiotoxicity: A Recent Five-Year Pharmacovigilance Study
por: Liu, Yihan, et al.
Publicado: (2022)

Editorial: Recent advances in attempts to improve medication adherence-from basic research to clinical practice
por: Kardas, Przemyslaw, et al.
Publicado: (2023)

Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development
por: Campana, Chiara, et al.
Publicado: (2021)

Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
por: Huang, Junqi, et al.
Publicado: (2022)

Analysis of clinical characteristics of mesalazine-induced cardiotoxicity
por: Chen, Junyu, et al.
Publicado: (2022)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023)

Editorial: Recent Advances in G Protein-Coupled Receptor Signalling: Impact of Intracellular Location, Environment and Biased Agonism
por: Halls, Michelle L., et al.
Publicado: (2021)

Editorial: Ocular Pharmacology: Recent Breakthroughs and Unmet Needs
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Structure Related Druggability of Voltage-Gated Sodium and Calcium Ion-Channels to Treat Diseases
por: Gamal El-Din, Tamer M., et al.
Publicado: (2022)

Editorial: Reducing the Harm of Medication–Recent Trends in Pharmacovigilance
por: Ramírez, Elena, et al.
Publicado: (2022)

Editorial: Recent trends in pharmacological treatment of musculoskeletal disorders
por: Zong, Zhixian, et al.
Publicado: (2022)

Cardiotoxicity of Cancer Therapeutics: Current Issues in Screening, Prevention, and Therapy
por: Sheppard, Richard J., et al.
Publicado: (2013)

Editorial: Advances and Challenges in Nanomedicine
por: Hua, Susan, et al.
Publicado: (2018)

Editorial: Advances in Drug Formulation
por: Mukherjee, Biswajit, et al.
Publicado: (2020)

Editorial: New Advances in RNA Targeting
por: Ilinskaya, Olga, et al.
Publicado: (2020)

Recent advances in voltage-gated sodium channels, their pharmacology, and related diseases
por: Desaphy, Jean-François, et al.
Publicado: (2013)

Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
por: Liu, Yihai, et al.
Publicado: (2021)

Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
por: Du, Shuxu, et al.
Publicado: (2018)

MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
por: Kawano, Ippei, et al.
Publicado: (2022)

Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?
por: Jiang, Yichuan, et al.
Publicado: (2023)

Engineered biomaterial delivery strategies are used to reduce cardiotoxicity in osteosarcoma
por: Hou, Yulin, et al.
Publicado: (2023)

Editorial: Re-emergence of neglected tropical diseases amid the COVID-19 pandemic: epidemiology, transmission, mitigation strategies, and recent advances in chemotherapy and vaccines
por: Mohapatra, Ranjan K., et al.
Publicado: (2023)

Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study
por: Hilmi, Marc, et al.
Publicado: (2020)

Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
por: Shim, Jaehee V., et al.
Publicado: (2023)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Editorial: Advances on targeted nanomedicines for atherosclerosis
por: Han, Qinggong, et al.
Publicado: (2022)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

Editorial: Advances in antimicrobial therapy and combating resistance
por: Ghazi, Islam M., et al.
Publicado: (2023)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
por: Zhang, Yili, et al.
Publicado: (2020)

Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity
por: Qin, Yeyu, et al.
Publicado: (2022)

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges
por: Gan, Lu, et al.
Publicado: (2022)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Editorial: Advancements in computational studies of drug toxicity
por: Flynn, Noah R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t80d9cnc8hsg76tifopmuv8juj